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What is already known about the topic?
•• There is a need to improve end-of-life care for people with end-stage kidney disease, including timely and appropriate 
Advance Care Planning discussions.
Thinking ahead – the need for  
early Advance Care Planning for  
people on haemodialysis: A qualitative 
interview study
Katherine Bristowe1, Helen L Horsley2, Kate Shepherd3, Heather 
Brown4, Irene Carey4, Beverley Matthews5, Donal O’Donoghue6, 
Katie Vinen3 and Felicity EM Murtagh1
Abstract
Background: There is a need to improve end-of-life care for people with end-stage kidney disease, particularly due to the increasingly 
elderly, frail and co-morbid end-stage kidney disease population. Timely, sensitive and individualised Advance Care Planning discussions 
are acceptable and beneficial for people with end-stage kidney disease and can help foster realistic hopes and goals.
Aim: To explore the experiences of people with end-stage kidney disease regarding starting haemodialysis, its impact on quality 
of life and their preferences for future care and to explore the Advance Care Planning needs of this population and the timing of 
this support.
Study design: Semi-structured qualitative interview study of people receiving haemodialysis. Interviews were analysed using thematic 
analysis. Recruitment ceased once data saturation was achieved.
Setting/participants: A total of 20 patients at two UK National Health Service hospitals, purposively sampled by age, time on 
haemodialysis and symptom burden.
Results: Themes emerged around: Looking Back, emotions of commencing haemodialysis; Current Experiences, illness and treatment 
burdens; and Looking Ahead, facing the realities. Challenges throughout the trajectory included getting information, communicating 
with staff and the ‘conveyor belt’ culture of haemodialysis units. Participants reported a lack of opportunity to discuss their future, 
particularly if their health deteriorated, and variable involvement in treatment decisions. However, discussion of these sensitive issues 
was more acceptable to some than others.
Conclusion: Renal patients have considerable unmet Advance Care Planning needs. There is a need to normalise discussions about 
preferences and priorities in renal and haemodialysis units earlier in the disease trajectory. However, an individualised approach is 
essential – one size does not fit all.
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Introduction
Over recent years, the end-stage kidney disease (ESKD) 
population has increased. The incidence of those receiving 
renal replacement therapy in the United Kingdom has risen 
from 60 per million population (pmp) (1990) to 108 pmp 
(2012)1,2 and in the United States from 198 pmp (1991) to 
348 pmp (2010).3,4 The ESKD population is also becoming 
increasingly elderly, frail and co-morbid,5 and the survival 
of dialysis patients, compared to an age-matched popula-
tion, is markedly reduced. In the United States, for those 
aged 50–54 years, survival is 7.1 years on dialysis com-
pared to 27.1 years in the normal population; for those 
aged 60–64 years, it is 5.1 years (compared to 19.2 years); 
for those aged 70–74 years, it is 3.6 years (compared to 
12.2 years) and for those aged 80–84 years, it is 2.0 years 
(compared to 6.7 years).6
Advance (or Anticipatory) Care Planning (ACP) is a 
process of discussion between an individual and his or 
her healthcare provider regarding concerns, goals, pref-
erences, prognosis and future care.7 In the UK ACP 
guidance, renal disease is used as an example where 
transitions between care phases represent an opportu-
nity to commence ACP. The importance of ACP for 
renal patients has been highlighted in recent research, 
particularly regarding symptom burden, quality of life 
and future care plans.8 ACP is most effective when indi-
vidually tailored, addressing patient and family con-
cerns,9,10 and, when appropriately timed, has been found 
to foster hope among renal patients.11 However, current 
provision of ACP for renal patients is inadequate and 
inconsistent. Patients report a preference for more infor-
mation and for ACP to commence earlier in their 
illness.9
Taking into account the changing population, there is a 
need for a culture shift from a ‘disease-focused’ model 
towards a ‘holistic care-based’ approach, normalising dis-
cussions about preferences, priorities and future care in 
renal units. The aim of this article is to explore the experi-
ences of haemodialysis (HD) patients regarding starting 
HD, its impact on quality of life and their preferences for 
future and end-of-life care, with a view to informing our 
understanding of the timing and provision of ACP for this 
population.
Methods
Setting
The study setting was two large London renal centres col-
lectively serving approximately 1000 HD patients at 2 
main and 10 geographically dispersed satellite units. Both 
offer a service comparable to other centres nationally, 
including low clearance clinics (providing advanced kid-
ney care for patients who may need renal replacement 
therapy within 6–12 months) and <20% of patients pre-
senting late.12
Participants
A total of 20 HD patients were purposely sampled by age 
(<65, 65 and over), time spent on HD (<12 months, 12–
36 months, >36 months) and symptom burden, recorded 
using a validated symptom measure (Palliative care 
Outcome Scale–Symptoms (POS-S) renal).8 The partici-
pants had a mean age of 62 years (median: 62.5 years, range: 
25–90 years), mean time spent on HD of 25 months (median: 
19.5 months, range: 3–60 months) and mean symptom score 
of 16 (median: 15, range: 2–35 of a possible 80) (see Table 1). 
Seven participants attended main HD units and 13 attended 
satellite units. In all, 11 participants were female and 9 male; 
10 were White British, 3 Black African, 4 Black Caribbean 
and 3 of Asian ethnicity. In the 20 months since completing 
the study, four participants have died.
Interviews
Ethical approval was obtained from the Local Research 
Ethics Committee (London Riverside NRES – Ref: 11/
LO/0286), and all procedures followed were in accordance 
with Declaration of Helsinki.13 Participants were recruited 
(November 2011–February 2012) through link nurses at 
each unit who explained the study and introduced the 
researcher (KB), a sociolinguist with extensive interview-
ing experience. The researcher further explained the pur-
pose of the study, and each participant gave informed 
consent before the interview.
The semi-structured interview schedule was guided by 
a literature review and informed by the multidisciplinary 
What this paper adds?
•• Haemodialysis patients are rarely given the opportunity to discuss their future care, should their health deteriorate, and 
describe Advance Care Planning needs before commencing haemodialysis and throughout their disease trajectory.
Implications for practice, theory or policy
•• There is a need to normalise discussions about preferences, priorities and future care in renal and haemodialysis units, 
earlier in the disease trajectory.
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research team and patient and family caregiver advisors. 
An observational log and field notes for each interview 
described the following: the flow of the interview, con-
textual factors, responses from the participant regarding 
the interview process and questions, and personal reflec-
tions. All participants chose to carry out the interview 
while receiving HD (home or other location also offered), 
no participants chose to withdraw from the study after 
consent was taken and many offered to be interviewed 
again for this or future studies. All interviews were digi-
tally audio-recorded (lasting on average 33 min, range: 
13–86 min) and transcribed verbatim, and recruitment 
continued until data saturation was achieved. Care was 
taken to use pseudonyms and anonymise any patient, or 
staff, identifiable references.
Analysis
Interviews were analysed (by KB and HH) using inductive 
thematic analysis, which involves five key stages: famil-
iarisation, coding, theme development, defining themes 
and reporting.14,15 Investigator triangulation was used to 
improve the confirmability of the findings (KB, HH, FM). 
Emergent themes were reviewed by a person with kidney 
failure to improve validity. Analysis was managed using 
N-Vivo qualitative data analysis software (version 10).
Results
Participants described considerable unmet and unad-
dressed ACP needs. These needs were broad-ranging; 
however, specifically they included fear, grief, denial, a 
shortage of information about their illness and progress, 
mixed experiences regarding involvement in decisions and 
a lack of opportunity to discuss their concerns, prognosis 
and future care. These needs extended from prior to com-
mencing HD and throughout their time on HD. Experiences 
could be categorised into three temporally discrete main 
themes (see Figure 1):
Looking back: emotions of commencing HD
Current experiences: illness and treatment burdens
Looking ahead: facing the realities
At all stages, however, the participants described a need 
for more emotional, psychological and practical support at 
transitional phases of their disease such as when com-
mencing HD or when deteriorating despite HD.
Looking back: emotions of commencing HD
Commencing HD was described by all participants, often 
in highly emotional terms. For many, the experience was 
associated with fear, sadness and disbelief.
Struggling. They described struggling to come to terms 
with the need to commence this invasive, but seemingly 
unavoidable, intervention, as recounted by Fiona:
I actually got in touch with the hospice and I was going to go 
in to palliative care … I just didn’t really want to live anymore 
because I thought I can’t live a life like this. It was so difficult 
in the beginning … you wouldn’t imagine how difficult it 
was. (Fiona, 46, 26 months on HD)
Denial. For some participants, there were periods of numb-
ness, disbelief and denial, particularly when first exposed 
to the HD unit, as explained by Edward:
Table 1. Interview participants.
Participants 20
Age (years)
 <65 11
 65 and over 9
Mean 62
Median 62.5
Range 25–90
Gender
 Female 11
 Male 9
Ethnicity
 Asian 3
 Black African 3
 Black Caribbean 4
 White British 10
Time spent on haemodialysis (months)
 <12 6
 12–36 7
 >36 7
Mean 25
Median 19.5
Range 3–60
POS-S renal symptom score
 <10 4
 10–20 8
 >20 5
 Not completed 3
Mean 16
Median 15
Range 2–35
Unit type
 Main 7
 Satellite 13
Experience of low clearance clinic
 Yes 16
 No 4
Died since participation in study
 Yes 4
 No 16
POS-S: Palliative care Outcome Scale–Symptoms
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When I went to the hospital and they were showing me 
round the unit and they’re showing me the machines and the 
patients and all I’m seeing is these tubes and the nurse 
talking to me. And all I’m thinking, I ain’t going on there. 
That’s all I’m thinking, ah no that’s not me. (Edward, 48, 
12 months on HD)
Fear. However, there were also periods of intense fear, as 
described by Carole:
They put a line in me … cause I had to get on the dialysis 
straight away, then they had the er about doing the bags. Oh, I 
cried my eyes out, I was terrified when all this at the beginning 
was going on. I was petrified. (Carole, 55, 47 months on HD)
Fears often had sensory associations: the size and 
sounds of the machines, the smells of the unit, the sight of 
the blood in the tubes and the invasiveness of the needles 
and fistulas.
Grief. For many, accepting the life-changing impact of their 
illness was associated with grief, intense sadness and anger 
at the loss of their health. For Fiona, this was compounded 
by an apparent lack of understanding from the HD nurses:
I had a lot of challenges with a lot of nurses at that time and 
they couldn’t understand why I was crying. They couldn’t 
understand why I was getting angry. You know I was grieving 
for my health. (Fiona, 46, 26 months on HD)
Realisation. Some participants, however, did describe a 
degree of acceptance or realisation of the place for HD in 
their life, albeit often reluctantly. Edward described this 
point of realisation:
Figure 1. Model of experiences described by people on haemodialysis.
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You tend to be in a state of denial … We have to handle 
ourselves and say, right, we have to do this. There’s going to 
be days where we don’t want to do it. We’re going to overcome 
this. We have to really get to realise, this is what’s keeping us 
alive. (Edward, 48, 12 months on HD)
However, for others, including Carole, acceptance and 
realisation remained absent due to the unrelenting grief:
I still won’t accept this dialysis. They said I can’t have another 
transplant. I just can’t accept it. Um, I feel alright yeah, but 
near enough every day I have a cry at home. (Carole, 55, 
47 months on HD)
Current experiences: illness and treatment 
burdens
Participants described at length the burden of undergoing 
HD, the physical environment and care received, the con-
siderable symptom burden, as well as the enormous impact 
of HD on their life and that of their family.
Care under the renal teams
Experiences at the unit. Many of the participants 
described a close and supportive relationship with the 
nurses and doctors, particularly those, such as Bernard, 
who had attended for many years:
I’m sitting here eating biscuits a cup of tea and a comfortable 
chair with a £10,000 machine keeping me alive. The nurses 
are wonderful, the atmosphere in the place is good. (Bernard, 
90, 53 months on HD)
However, for others the experience was marred by the 
‘conveyor belt’ culture that pervaded, with prioritisation of 
‘getting you on and off’ rather than caring for the individ-
ual. This experience was compounded for those reliant on 
hospital transport, for which there was often a lengthy wait 
– a 4-h HD session becoming a 12-h ordeal, impacting 
severely upon recovery the next day.
Managing symptoms. Many participants reflected on the 
busy culture of the unit and the associated lack of opportu-
nity to speak to a doctor. For those who were symptomatic 
or became unwell while on HD, this was particularly chal-
lenging.
Communication with the unit staff/getting information. The 
reported infrequent presence of the doctors also impacted 
patients’ ability to gain information and explanations about 
their illness and progress:
I know you’re made aware of what’s happening around you 
but I think you should be more, more explained to you … I 
know we get leaflet and things like that, what you should eat 
and what you shouldn’t eat, but I think you want somebody to 
really take it in and explain to you in detail. (Victoria, 72, 
60 months on HD)
Participants also described a culture of silence when a 
fellow patient, with whom they had often shared a cubicle 
for years, no longer attended for HD, as depicted by 
Bernard:
No they’re very careful of trying not to tell you too much … 
they would … try and answer a question but without, then 
suddenly somebody’s not here. (Bernard, 90, 53 months on HD)
Involvement in treatment decisions. Experiences of 
involvement in treatment decisions were very varied. 
Some, including Victoria, felt they had not been adequately 
involved, or not in a timely manner:
Could have been more involved. I could have been because 
I think you’d have to say oh why didn’t they tell me, or 
why didn’t they tell me there and then I heard at a later 
date. You want to know here and now. (Victoria, 72, 
60 months on HD)
For others, autonomy in treatment decisions was 
achieved. Rebecca described the decision to return to HD, 
when her health began to deteriorate after a failed 
transplant:
It was my decision in the end that I waited and waited and I 
was far from well by the time I came back. I knew I should 
come back on but I was just postponing the dreading time I 
would become a slave to time and machines. No I’ve always 
been allowed to make my decisions, even when I’d known 
I’m wrong. (Rebecca, 69, 16 months on HD)
However, not everyone wanted to be involved in treat-
ment decisions. John, for example, actively avoided 
involvement in decisions, preferring to leave this to the 
renal care team:
No I just like to, come up here, have this done for 3 hours and 
I just like to go, get back home … I don’t want to get involved 
in anything, as long as I’m still breathing and I can get home 
to my wife that’s all I need. (John, 77, 24 months on HD)
Living with HD
Impact on day-to-day life. The participants talked 
openly about the overwhelming impact of kidney fail-
ure, and HD, upon their lives and their struggle to 
accept a new reality. This impact, as described by Car-
ole, was compounded by the cyclical nature of dialysis, 
with every weekend overshadowed by the foreboding 
HD routine:
Everything’s changed, every single thing … Well I can’t walk, 
I can’t eat everything what I fancy, I can’t drink really what I 
want … to drink. Oh life stinks, horrible, can’t stand it. 
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Terrible times this is. Doesn’t hurt having it done … but oh 
my god Sunday nights, they’re a git. (Carole, 55, 47 months 
on HD)
Almost all participants, including Fiona, described the 
devastating loss of independence and enjoyment in 
activities:
The dancing, you know I love dancing, I was always on a 
high. I’ve always loved my music and I’ve always loved 
dancing, so for me, like apart from reading and visiting places 
of interest, that seemed to fall away because I was too tired to 
go anywhere. (Fiona, 46, 26 months on HD)
Impact on friends and family. This impact extended to 
friends and family also, with many participants needing to 
rely heavily on them:
You know they can’t get on with their life cause I can’t get on 
with mine, cause I’m stuck on this. Too busy helping me out 
with my little girl. So it’s a lot of strain and pressure yes on the 
family and friends. (Denise, 39, 23 months on HD)
However, some participants also described the loss of 
friends when the illness became apparent and the subse-
quent isolation.
Looking ahead: facing the realities
Many participants talked about the future – thinking about 
their future care and their own mortality.
Facing own mortality. They reflected on the death of fellow 
patients and their fears of becoming unwell while receiv-
ing HD, as described by Carole:
Yeah I think about it all the time, you know cause other people 
have heart attacks you know on the machines. We’ve lost two 
in this cubicle … But I’m always thinking about it, always. 
(Carole, 55, 47 months on HD)
However, for Tia, the thoughts regarding her mortality 
tended to overshadow her time at home, with her family, 
much to the detriment of her relationship with her husband 
and daughter:
I have a problem of, I say, before I die. I keep saying that 
lately, I don’t know why. And it’s really affecting my daughter 
I need to stop it, but I say before I die I need to do this I need 
to do that. (Tia, 38, 10 months on HD)
However, some participants did not admit to concerns 
about mortality, preferring to live for the moment, or not to 
concern themselves with that which is out of their control. 
For some participants, such as Margaret, this decision was 
driven by their faith:
I don’t think about that. I don’t have to think about it, I can’t 
do nothing about what is going on. So I just, i’m the sort of 
person that believes in God, so I feel that he that made me 
knows his purpose. So it’s up to him what he wants to do. I 
just leave it at that. (Margaret, 59, 12 months on HD)
Talking about future care. Many participants described 
concerns regarding future treatment and hospitalisation, 
and maintaining attendance for HD, should their health 
deteriorate. For some, these fears were exacerbated due 
to underlying concerns about leaving a spouse to cope 
alone, while for others, including Audrey, the concern 
was more about the logistics of attending for HD with 
failing mobility:
Well, the only thing is, what has worried me is, if I couldn’t 
get out, to come up here I mean. Would they bring me on a 
stretcher or something like that? I don’t know. Now and again 
it just wanders through your mind and you think, well we’ll 
come to that position when we come to it you know. (Audrey, 
82, 41 months on HD)
For many of the participants, the lack of opportunity to 
discuss their concerns about their declining health and 
future care was compounded by not knowing to whom 
they should direct their concerns and not wanting to be ‘a 
bother’. Unless a discussion was instigated by a member 
of the team caring for them, they would not have an oppor-
tunity to raise their concerns.
Discussion
This study demonstrates the considerable unmet informa-
tion and ACP needs of people with ESKD throughout their 
illness. This concurs with pre-existing evidence from 
Canada and the United States.9,10,16 For many participants, 
the transition to starting HD was abrupt; they felt unpre-
pared for the overwhelming impact of HD, despite most 
having attended low clearance clinics. This disruption to 
their life, shattering of hopes and loss of self are described 
extensively in the chronic disease literature.17–19 However, 
unlike some other disease groups with an unpredictable 
onset, patients with renal failure usually have the potential 
to be supported during this period of deterioration to facili-
tate a stepwise adjustment to life with HD. Indeed, the 
majority of the patients in this study attended a low clear-
ance clinic. However, instead, the participants described a 
lack of information or discussion before commencing HD, 
compounding their shock. This need for earlier engagement 
in ACP,11 and support at transitional phases of illness,20 has 
been described in the literature and could ameliorate emo-
tional, psychological and practical issues associated with 
the adjustment to life while receiving HD.21
Provision of support and discussion of preferences 
and priorities are particularly important for the younger 
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patients receiving HD. These participants described strug-
gling to maintain a career, family life and roles (spouse, 
partner, parent or child), alongside HD. For these partici-
pants, the ability to maintain these roles was of paramount 
importance, and they described a need to oscillate between 
their home self and HD self. This is exaggerated by the 
fluctuant disease trajectories associated with chronic kid-
ney disease22 and the ‘one-day-on, one-day off’ structure 
of HD. For these patients, the need to commence ACP ear-
lier in the disease trajectory is particularly valuable in 
order to help them foster realistic hopes and goals.11
However, there is also considerable need for ACP 
among the older patients receiving HD. For those over 
65 years, one in four will die within 1 year,23 so the need 
for discussions about preferences and priorities for future 
care is particularly pressing. In 2005, just under two-third 
of the UK population reported a longstanding illness, and 
the population is predicted to continue to age over the next 
two decades.24 It is therefore increasingly important for 
healthcare providers to understand the complex and evolv-
ing needs and preferences of older people with chronic ill-
nesses in order to optimise care and to ensure the most 
efficient use of services in the future.
The results from this study highlight the importance of 
ACP and information sharing that is tailored to individual 
preferences and priorities, as evidenced in previous 
research.9 Although some patients reported a desire to 
commence discussions about their health, future care and 
priorities, for some these discussions were not welcome at 
this stage. Importantly however, many patients receiving 
HD remain unaware of the supportive care available to 
them16 or even to whom they should direct their concerns. 
This has been identified in previous research in HD units, 
describing a focus on ‘nursing the machine’ (attending to 
the HD process), with little attention to the holistic needs 
of the patient.25 Some possible actions to address these 
issues could include communication training for HD staff 
in renal-specific ACP,26 regular exploration of patients’ 
clinical status, symptoms, quality of life, concerns and pri-
orities, perhaps during HD session, to identify those with 
most need, and annual review with the patient and family 
to discuss any changes in the last year.27
Using qualitative methods, it is not possible to make 
judgements as to the generalisability of these results. 
However, purposive sampling was used to capture diver-
sity among participants’ experiences to improve transfer-
ability. Investigator triangulation was used to explore the 
robustness of the analysis, discreteness and interactivity 
of themes, and to explore deviant cases, to ensure credi-
bility, dependability and confirmability of the findings. 
Subsequent studies would benefit from a longitudinal 
approach to explore the evolving nature of preferences 
and priorities and the shifting role of ACP for this popula-
tion, as well as the management of transitional phases in 
renal disease.
Conclusion
There is a need to normalise discussions about concerns, 
fears, preferences, priorities and future care for those with 
kidney failure throughout the renal pathway to enable a 
culture change to best meet the needs of this population. 
This can only be achieved by strengthening the support 
available to those with kidney failure and continued educa-
tion and training of renal staff to minimise the avoidance 
of such discussion due to fear of causing distress. Such 
training should be tailored to highlight the importance of 
clear information giving, of ACP, where appropriate, and 
the diverse and evolving needs of this population.
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